Summary Table 2. Preoperative diagnosis

Author, year, LocationSample descriptionNo. EligibleMeasurement PeriodRate (%)/Key differences
Appropriate use of imaging &/or cytology or needle biopsy, if required, to be performed at the initial visit IV
Cheung, 1999, Hong KongConvenience sample of women with operable primary BC <5 cm; attended by the author100NR0%/NA
Appropriate use of preoperative diagnosis by fine-needle aspiration cytology, needle histology or biopsy IV
Sauven, 2003, UKPopulation-based sample BC women detected by screening in UK, Wales, Scotland & Northern Ireland43,5001996-2001NR (Overall by y (range): 63% – 87%(Minimum: ≥70%; Standard: ≥90%))/NA
Christensen, 2002, DenmarkConvenience sample women with positive mammography screening followed by surgery in Copenhagen4,1111991-1997NA/100%
Cheung, 1999, Hong KongConvenience sample women operable primary BC <5 cm; attended by the author100NR82% (Standard: 90%)/NA
McCarthy, 1997, UKConvenience sample women with operable BC, <70 y treated at Nottingham City Hospital's83199486.7% (Standard: ≥70%)/NA
Appropriate use: A biopsy or fine-needle aspiration should be performed within 6 weeks either when the mammography suggests malignancy or the persistent palpable mass is not cystic on ultrasound IV
McGlynn, 2003, USRandom sample of women living in 12 US metropolitan areas331998-200050.2%/NA
Appropriate use: If a breast mass has been detected on two separate occasions, then either a biopsy, fine-needle aspiration or ultrasound should be performed within 3 months of the second visit IV
McGlynn, 2003, USRandom sample of women living in 12 US metropolitan areas131998-200081.6%/NA
Quality of fine-needle aspiration samples from lesions, which subsequently prove to be breast cancer, should be adequate as deemed by the breast pathologist IV
Cheung, 1999, Hong KongConvenience sample women with operable primary BC < 5 cm; attended by the author100NR99% (Standard: >90%)/NA

From: Summary Tables

Cover of Measuring the Quality of Breast Cancer Care in Women
Measuring the Quality of Breast Cancer Care in Women.
Evidence Reports/Technology Assessments, No. 105.
Schachter HM, Mamaladze V, Lewin G, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.